Development of a real-time SYBRGreen PCR assay for rapid detection of acquired AmpC in Enterobacteriaceae

Journal of Microbiological Methods

Volumn 82, Issue 3, 2010, Pages 229-233

  Brolund, Alma ^a,b   Tegmark Wisell, Karin ^a,b   Edquist, Petra J ^a   Elfström, Lisbeth ^c   Walder, Mats ^c   Giske, Christian G ^b,d  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CMY; DHA; ESBL; Escherichia coli; Klebsiella pneumoniae

Indexed keywords

BETA LACTAMASE AMPC; BETA LACTAMASE CMY 16; BETA LACTAMASE CMY 2; BETA LACTAMASE DHA 1; CEFOXITIN; CLAVULANIC ACID; CLOXACILLIN; EXTENDED SPECTRUM BETA LACTAMASE; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DNA MODIFICATION; DNA SEQUENCE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GENETIC ANALYSIS; GENOTYPE; KLEBSIELLA PNEUMONIAE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PULSED FIELD GEL ELECTROPHORESIS; REAL TIME POLYMERASE CHAIN REACTION; REPLICON; SCREENING TEST; SEQUENCE ANALYSIS;

ENTEROBACTERIACEAE; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE;

EID: 77955659288     PISSN: 01677012     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mimet.2010.06.006     Document Type: Article

References (32)

1. Carattoli A. Resistance plasmid families in Enterobacteriaceae. Antimicrob. Agents Chemother. 2009, 53:2227-2238.
2. Carattoli A., Bertini A., Villa L., Falbo V., Hopkins K.L., Threlfall E.J. Identification of plasmids by PCR-based replicon typing. J. Microbiol. Meth. 2005, 63:219-228.
3. D'Andrea M.M., Nucleo E., Luzzaro F., Giani T., Migliavacca R., Vailati F., Kroumova V., Pagani L., Rossolini G.M. CMY-16, a novel acquired AmpC-type beta-lactamase of the CMY/LAT lineage in multifocal monophyletic isolates of Proteus mirabilis from northern Italy. Antimicrob. Agents Chemother. 2006, 50:618-624.
4. Gaillot O., Clement C., Simonet M., Philippon A. Novel transferable beta-lactam resistance with cephalosporinase characteristics in Salmonella enteritidis. J. Antimicrob. Chemother. 1997, 39:85-87.
5. Giske C.G., Haldorsen B., Lundblad E.W., Aasnaes B., Simonsen G.S., Sundsfjord A. Phenotypic detection of AmpC in E. coli: comparison of claoxacillin, boronic acid and EDTA disk synergy assays. ECCMID European Congress of Clinical Microbiology and Infectious Diseases 2007, Vol. P871. Munich, Germany.
6. Giske C.G., Sundsfjord A.S., Kahlmeter G., Woodford N., Nordmann P., Paterson D.L., Canton R., Walsh T.R. Redefining extended-spectrum beta-lactamases: balancing science and clinical need. J. Antimicrob. Chemother. 2009, 63:1-4.
7. Gray J.T., Hungerford L.L., Fedorka-Cray P.J., Headrick M.L. Extended-spectrum-cephalosporin resistance in Salmonella enterica isolates of animal origin. Antimicrob. Agents Chemother. 2004, 48:3179-3181.
8. Haldorsen B., Aasnaes B., Dahl K.H., Hanssen A.M., Simonsen G.S., Walsh T.R., Sundsfjord A., Lundblad E.W. The AmpC phenotype in Norwegian clinical isolates of Escherichia coli is associated with an acquired ISEcp1-like ampC element or hyperproduction of the endogenous AmpC. J. Antimicrob. Chemother. 2008, 62:694-702.
9. Hanson N.D., Moland E.S., Hong S.G., Propst K., Novak D.J., Cavalieri S.J. Surveillance of community-based reservoirs reveals the presence of CTX-M, imported AmpC, and OXA-30 beta-lactamases in urine isolates of Klebsiella pneumoniae and Escherichia coli in a U.S. community. Antimicrob. Agents Chemother. 2008, 52:3814-3816.
10. Iabadene H., Messai Y., Ammari H., Alouache S., Verdet C., Bakour R., Arlet G. Prevalence of plasmid-mediated AmpC beta-lactamases among Enterobacteriaceae in Algiers hospitals. Int. J. Antimicrob. Agents 2009, 34:340-342.
11. Jacoby G.A. AmpC beta-lactamases. Clin. Microbiol. Rev. 2009, 22:161-182. Table of Contents.
12. Kang H.Y., Kim J., Seol S.Y., Lee Y.C., Lee J.C., Cho D.T. Characterization of conjugative plasmids carrying antibiotic resistance genes encoding 16S rRNA methylase, extended-spectrum beta-lactamase, and/or plasmid-mediated AmpC beta-lactamase. J. Microbiol. 2009, 47:68-75.
13. Luzzaro F., Brigante G., D'Andrea M.M., Pini B., Giani T., Mantengoli E., Rossolini G.M., Toniolo A. Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management. Int. J. Antimicrob. Agents 2009, 33:328-333.
14. Mammeri H., Eb F., Berkani A., Nordmann P. Molecular characterization of AmpC-producing Escherichia coli clinical isolates recovered in a French hospital. J. Antimicrob. Chemother. 2008, 61:498-503.
15. Maslow J.N., Slutsky A., Arbeit R.D. Application of Pulsed-field Gel Electrophoresis to Molecular Epidemiology 1993, ASM Press, Washington, D.C.
16. Mata C., Miro E., Rivera A., Mirelis B., Coll P., Navarro F. Prevalence of acquired AmpC beta-lactamases in Enterobacteriaceae lacking inducible chromosomal ampC genes at a Spanish hospital from 1999 to 2007. Clin. Microbiol. Infect. 2010, 16:472-476.
17. Mataseje L.F., Neumann N., Crago B., Baudry P., Zhanel G.G., Louie M., Mulvey M.R. Characterization of cefoxitin-resistant Escherichia coli isolates from recreational beaches and private drinking water in Canada between 2004 and 2006. Antimicrob. Agents Chemother. 2009, 53:3126-3130.
18. Mulvey M.R., Susky E., McCracken M., Morck D.W., Read R.R. Similar cefoxitin-resistance plasmids circulating in Escherichia coli from human and animal sources. Vet. Microbiol. 2009, 134:279-287.
19. Naseer U., Haldorsen B., Simonsen G.S., Sundsfjord A. Sporadic occurrence of CMY-2-producing multidrug-resistant Escherichia coli of ST-complexes 38 and 448, and ST131 in Norway. Clin. Microbiol. Infect. 2010, 16:171-178.
20. Normark S., Lindquist S., Lindberg F. Chromosomal beta-lactam resistance in enterobacteria. Scand. J. Infect. Dis. Suppl. 1986, 49:38-45.
21. Pai H., Kang C.I., Byeon J.H., Lee K.D., Park W.B., Kim H.B., Kim E.C., Oh M.D., Choe K.W. Epidemiology and clinical features of bloodstream infections caused by AmpC-type-beta-lactamase-producing Klebsiella pneumoniae. Antimicrob. Agents Chemother. 2004, 48:3720-3728.
22. Perez-Perez F.J., Hanson N.D. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 2002, 40:2153-2162.
23. Philippon A., Arlet G., Jacoby G.A. Plasmid-determined AmpC-type beta-lactamases. Antimicrob. Agents Chemother. 2002, 46:1-11.
24. Pitout J.D., Gregson D.B., Church D.L., Laupland K.B. Population-based laboratory surveillance for AmpC beta-lactamase-producing Escherichia coli, Calgary. Emerg. Infect. Dis. 2007, 13:443-448.
25. Pitout J.D., Le P.G., Moore K.L., Church D.L., Gregson D.B. Detection of AmpC beta-lactamases in Escherichia coli, Klebsiella spp., Salmonella spp. and Proteus mirabilis in a regional clinical microbiology laboratory. Clin. Microbiol. Infect. 2010, 16:165-170.
26. Sanger F., Coulson A.R. A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase. J. Mol. Biol. 1975, 94:441-448.
27. Shi W.F., Zhou J., Qin J.P. Transconjugation and genotyping of the plasmid-mediated AmpC beta-lactamase and extended-spectrum beta-lactamase genes in Klebsiella pneumoniae. Chin. Med. J. (Engl.) 2009, 122:1092-1096.
28. Sidjabat H.E., Paterson D.L., Qureshi Z.A., Adams-Haduch J.M., O'Keefe A., Pascual A., Rodriguez-Bano J., Doi Y. Clinical features and molecular epidemiology of CMY-type beta-lactamase-producing Escherichia coli. Clin. Infect. Dis. 2009, 48:739-744.
29. Tan T.Y., Ng L.S., He J., Koh T.H., Hsu L.Y. Evaluation of screening methods to detect plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis. Antimicrob. Agents Chemother. 2009, 53:146-149.
30. Walther-Rasmussen J., Hoiby N. Plasmid-borne AmpC beta-lactamases. Can. J. Microbiol. 2002, 48:479-493.
31. Winokur P.L., Brueggemann A., DeSalvo D.L., Hoffmann L., Apley M.D., Uhlenhopp E.K., Pfaller M.A., Doern G.V. Animal and human multidrug-resistant, cephalosporin-resistant Salmonella isolates expressing a plasmid-mediated CMY-2 AmpC beta-lactamase. Antimicrob. Agents Chemother. 2000, 44:2777-2783.
32. Woodford N., Dallow J.W., Hill R.L., Palepou M.F., Pike R., Ward M.E., Warner M., Livermore D.M. Ertapenem resistance among Klebsiella and Enterobacter submitted in the UK to a reference laboratory. Int. J. Antimicrob. Agents 2007, 29:456-459.